Skip to content

To establish Snehapana as a treatment option in Migraine.

To Compare the Efficacy of Nasyakarma and Snehapana in the Managment of Ardhavbhedaka with special refrence to Migraine. - YES

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/08/035968
Enrollment
60
Registered
2021-08-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G439- Migraine, unspecified

Interventions

Intervention1: Nasyakarma 14 days: nasyakarma with virhatjivakadya taia for 14 daya and follow up on 15th and 30th day Control Intervention1: Snehapana 14 day: Snehapana with Virhatjivakadya taila fo

Sponsors

National Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients between 18-60 years of age.. 2.Patients with clinical signs and symptoms of Ardhavbhedaka. (Ardhshirovedna, bhrushankha vedna, Shashtravatvedna, Shirahshoola, manya vedna,karna akshi lalat vedna) Migraine. 3.Patients of either gender. 4.Patients who uses analgesic and other medication. 5.Patients fit for Nasyakarma and Snehapana. 6.Patients willing to participate in trial and follow up with a signed informed consent

Exclusion criteria

Exclusion criteria: 1. Patients with severe systemic disorders as Uncontrolled Hypertension, Cardiac Problem, Diabetes Mellitus, Tuberculosis, Leprosy, Paralysis, malignant disease etc. 2. Patients of sinusitis, hemiplegic migraine, basilar migraine, retinal migraine, status migraines. 3. Headache due to obtains any organic lesion. 4. Headache due to injuries. 5. Headache due to any chronic systemic disease. 6. Pregnant womenâ??s or lactating women.

Design outcomes

Primary

MeasureTime frame
The assessment will be done by MIDAS (Migraine Disability Assessment Scale) before and after treatment.Timepoint: 30 Days

Secondary

MeasureTime frame
Migraine specific quality of life questionnaires.Timepoint: 30 Days

Countries

India

Contacts

Public ContactDr Sarvesh Kumar Singh

National Institute of Ayurveda

sarveshksingh21@gmail.com87398602377

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026